Xeltis announced the completion of enrollment in its European Union (EU) pivotal trial for the aXess restorative vascular access ...

Before 1998, urokinase was considered standard therapy for the management of occluded hemodialysis catheters. The dose of 5000 units per port appears on the FDA-approved labeling for urokinase.

The goal of the trial was to evaluate rates of catheter colonization and bloodstream infection with jugular catheterization compared with femoral catheterization among intensive care unit patients ...

After hours: January 6 at 6:20:30 PM EST Loading Chart for ARW ...

Dialysis may cause many side effects, of which, itchy skin, muscle cramps, and high blood pressure are common. Speak with your doctor about your concerns and how you can manage or prevent some ...

After hours: January 3 at 7:59:34 PM EST Loading Chart for VTAK ...

Figure 1. Cause of death in prevalent dialysis patients in the United States, 2005 to 2007. 1 AMI indicates acute myocardial infarction; CHF, congestive heart failure; CVA, cerebrovascular accident.